ZC-B

Last updated

ZC-B
WO2021-0137908-1 structure.png
Identifiers
  • 3-(4-bromo-2,5-dimethoxyphenyl)azetidine
CAS Number
PubChem CID
UNII
Chemical and physical data
Formula C11H14BrNO2
Molar mass 272.142 g·mol−1
3D model (JSmol)
  • COC1=CC(=C(C=C1C2CNC2)OC)Br
  • InChI=1S/C11H14BrNO2/c1-14-10-4-9(12)11(15-2)3-8(10)7-5-13-6-7/h3-4,7,13H,5-6H2,1-2H3
  • Key:YFCASESLVDHSAW-UHFFFAOYSA-N

ZC-B (3-(4-bromo-2,5-dimethoxyphenyl)azetidine) is a phenethylamine derivative which acts as a serotonin receptor agonist selective for the 5-HT2 subtypes, with an EC50 of 1.6nM at 5-HT2A, vs 5.8nM at 5-HT2C. It is structurally related to the psychedelic phenethylamines 2C-B and DOB, but with the amine side chain conformationally restricted as an azetidine ring. [1] [2] [3]

See also

References

  1. US 2021/0137908,Kristensen JL, Jensen AA, Märcher-Rørsted E,"5-HT2A Agonists for Use in Treatment of Depression.",published 13 May 2021, assigned to Lophora ApS.
  2. WO 2022/221774,Johnson G, Nichols DE, Maillet EL,"Aryl-ring-substituted 3-phenylazetidines and their use in methods for treating 5-HT2 responsive conditions",published 2022-10-20, assigned to leusis Therapeutics US Inc.
  3. Sabnis RW (September 2025). "Novel Compounds as 5‑HT2A Agonists for Treating Depression". ACS Medicinal Chemistry Letters. 16 (9): 1709–1710. doi:10.1021/acsmedchemlett.5c00461. PMID   40959260.